Razis, E., Vlahovic, G., Recht, L., Wheeler, H., Reardon, D., Fisher, P. G., … Hottinger, A. F. (2014). IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE. Neuro-Oncology, 16(suppl 5), v115–v116. https://doi.org/10.1093/neuonc/nou258.26

Razis, E., G. Vlahovic, L. Recht, H. Wheeler, D. Reardon, P. G. Fisher, S. Owen, et al. “IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE.” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v115–16. https://doi.org/10.1093/neuonc/nou258.26.

Razis E, Vlahovic G, Recht L, Wheeler H, Reardon D, Fisher PG, et al. IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE. Neuro-Oncology. 2014 Nov 1;16(suppl 5):v115–6.

Razis, E., et al. “IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v115–16. Crossref, doi:10.1093/neuonc/nou258.26.

Razis E, Vlahovic G, Recht L, Wheeler H, Reardon D, Fisher PG, Owen S, Nicholas K, Paradise E, Yellin M, Davis T, Weller M, Stupp R, Hottinger AF. IT-28 * VACCINATION AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III IN GLIOBLASTOMA: THE RINDOPEPIMUT COMPASSIONATE USE EXPERIENCE. Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v115–v116.